NasdaqGM - Delayed Quote USD

Barinthus Biotherapeutics plc (BRNS)

Compare
1.0300
-0.1100
(-9.65%)
At close: January 10 at 4:00:00 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
214,506.0000
270,205.0000
280,715.0000
50,666.0000
Total Liabilities Net Minority Interest
27,511.0000
27,004.0000
28,153.0000
87,578.0000
Total Equity Gross Minority Interest
186,995.0000
243,201.0000
252,562.0000
-36,912.0000
Total Capitalization
186,784.0000
242,896.0000
252,125.0000
7,397.0000
Common Stock Equity
186,784.0000
242,896.0000
252,125.0000
-37,303.0000
Capital Lease Obligations
12,976.0000
8,773.0000
7,063.0000
1,664.0000
Net Tangible Assets
149,467.0000
202,418.0000
208,065.0000
-37,303.0000
Working Capital
144,307.0000
200,799.0000
215,607.0000
40,260.0000
Invested Capital
186,784.0000
242,896.0000
252,284.0000
7,397.0000
Tangible Book Value
149,467.0000
202,418.0000
208,065.0000
-37,303.0000
Total Debt
12,976.0000
8,773.0000
7,222.0000
46,364.0000
Net Debt
--
--
--
1,434.0000
Share Issued
38,643.5400
37,683.5310
37,188.7300
34,064.3450
Ordinary Shares Number
38,643.5400
37,683.5310
37,188.7300
34,064.3450
12/31/2020 - 4/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers